Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s stock price shot up 17.9% during trading on Friday . The stock traded as high as C$0.23 and last traded at C$0.23. 714,214 shares were traded during mid-day trading, an increase of 122% from the average session volume of 321,276 shares. The stock had previously closed at C$0.20.
Theralase Technologies Trading Up 25.6%
The company has a current ratio of 1.91, a quick ratio of 3.40 and a debt-to-equity ratio of 14.85. The business has a 50 day simple moving average of C$0.17 and a two-hundred day simple moving average of C$0.19. The stock has a market cap of C$62.98 million, a price-to-earnings ratio of -13.61 and a beta of -0.35.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Read More
- Five stocks we like better than Theralase Technologies
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
